Headquartered in Shanghai, China, Unibio Lab is a science-driven probiotic CDMO specializing in clinically studied strains, advanced delivery technologies, and next-generation probiotics for global healthcare, nutrition, and food industries.
With over 40 years of probiotic research experience, Unibio Lab focuses on the development and commercialization of strain-specific, evidence-based probiotic solutions. Our portfolio includes human clinically validated strains, the proprietary VPro® five-layer microencapsulation technology for enhanced stability and targeted delivery, as well as next-generation probiotics such as Akkermansia muciniphila AH39 and Clostridium butyricum CCFM1299.
Backed by a 30,000+ strain bank, dozens of clinical research strains, and 500+ patented strains, Unibio Lab collaborates closely with leading academic institutions to translate scientific discoveries into scalable, high-quality probiotic products. Through our integrated CDMO platform, we empower partners worldwide to bring safe, effective, and innovative probiotics to market with confidence.
◆ To advance global health through next-generation precision probiotics
◆ Integrating scientific innovation, clinically validated strains, and full-spectrum industrial capabilities
◆ To make health easier and more accessible
Advanced Fermentation Systems
Large-Scale Production Lines
Precision Bioreactor Suite
Automated Purification & Formulation
Full-Scale GMP Production Facility
Get a tailored quote for your capsule, sachet or tablet project today.
Copyright © Shanghai Unibio Lab Co., Ltd.All Rights Reserved. - Privacy Policy
EN
